SUMATRIPTAN SUCCINATE INJECTION
DIBBS awards by month · trailing 12 mo
2 total
Price to win
From deduped DIBBS award lines (unit cost × quantity). Not a bid recommendation — observed history only.
Average unit cost
$449.28
Weighted average
$460.63
Weighted by quantity
Observed range
$49.84–$672
Coverage
20 awards
Jul 10, 2015 – Jul 21, 2026
Average: $449.28 · Weighted avg: $460.63 · Range: $49.84–$672.47 · Based on 20 awards, Jul 10, 2015–Jul 21, 2026.
Unit cost by award date · 20 priced lines
DIBBS award history
Distinct award lines for this NSN (deduped). Line total is unit cost × quantity.
20 distinct award lines
| Date | Manufacturer | Qty × unit | Total | Contract |
|---|---|---|---|---|
| Jul 21, 2026 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $49.84 | $50 | SPE2DP26F7886 |
| Dec 29, 2025 | 3W8H0MR UNLIMITED, LLCBRENHAM, TXSAM | 2 × $660.50 | $1,321 | SPE2DP26V0275 |
| Jul 14, 2022 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 2 × $660.51 | $1,321 | SPE2D922F3616 |
| Apr 25, 2022 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 2 × $660.51 | $1,321 | SPE2D922F2445 |
| Jul 13, 2021 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 2 × $672.47 | $1,345 | SPE2DP21F4983P00001 |
| May 4, 2021 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $672.47 | $672 | SPE2DP21F3757 |
| Oct 12, 2019 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $644.61 | $645 | SPE2DP20F0208 |
| Mar 25, 2018 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 2 × $499.16 | $998 | SPE2DP18F2408 |
| Mar 2, 2018 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $499.16 | $499 | SPE2DP18F2081 |
| Nov 3, 2017 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $488.27 | $488 | SPE2DP18F0567 |
| Jul 24, 2017 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $496.21 | $496 | SPE2DX15D93835965 |
| Feb 15, 2017 | 1UNB0DMS PHARMACEUTICAL GROUP INCPARK RIDGE, ILSAM | 1 × $496.21 | $496 | SPE2DX15D93834687 |
| Jul 22, 2016 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 2 × $281.46 | $563 | SPE2DX15D00227707 |
| May 9, 2016 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 2 × $281.46 | $563 | SPE2DX15D00226918 |
| Feb 15, 2016 | 00E55CARDINAL HEALTH, INC.DUBLIN, OHSAM | 1 × $281.46 | $281 | SPE2DX15D00225373 |
Manufacturers who have won this NSN
Distinct CAGEs with a confirmed DIBBS award line for this part — each opens the manufacturer page.
Approved manufacturers
Qualified to supply per MCRL — no confirmed DIBBS award on record for this NSN. Each CAGE opens the manufacturer page.
PN NDC00173-0449-02
PN NDC00173-0449-02
PN NDC00173-0449-02
PN IMITREX, IMITREX INJECTION, NDC00173-0449-02
PN NDC00173-0449-02
Characteristics
FLIS item characteristics from PUB LOG identification.
| Characteristic | Value |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS 6.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S |
| PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 2.000 |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| THERAPEUTIC EQUIVALENT | TO IMITREX BY GLAXO |
| TOTAL PRIMARY CONTAINER QUANTITY | 5 |
Open buys
DIBBS · quotes by Sep 23, 2026 · UNRESTRICTED
